nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0954	0.17	CbGbCtD
Lercanidipine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0954	0.17	CbGbCtD
Lercanidipine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.085	0.152	CbGbCtD
Lercanidipine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.08	0.143	CbGbCtD
Lercanidipine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0541	0.0965	CbGbCtD
Lercanidipine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0516	0.0921	CbGbCtD
Lercanidipine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.046	0.0821	CbGbCtD
Lercanidipine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.027	0.0482	CbGbCtD
Lercanidipine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0255	0.0455	CbGbCtD
Lercanidipine—CACNA1C—Nicotine Activity on Chromaffin Cells—CHRNA3—chronic obstructive pulmonary disease	0.0107	0.174	CbGpPWpGaD
Lercanidipine—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00258	0.0419	CbGpPWpGaD
Lercanidipine—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00228	0.0371	CbGpPWpGaD
Lercanidipine—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00186	0.0303	CbGpPWpGaD
Lercanidipine—CACNA1D—Regulation of insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.00174	0.0283	CbGpPWpGaD
Lercanidipine—CACNA1C—Regulation of insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.00153	0.0249	CbGpPWpGaD
Lercanidipine—Nisoldipine—CYP1A2—chronic obstructive pulmonary disease	0.00142	0.294	CrCbGaD
Lercanidipine—CACNA1D—Integration of energy metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00137	0.0223	CbGpPWpGaD
Lercanidipine—Nilvadipine—CYP1A2—chronic obstructive pulmonary disease	0.00133	0.275	CrCbGaD
Lercanidipine—CYP3A7—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00122	0.0198	CbGpPWpGaD
Lercanidipine—CACNA1C—Integration of energy metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.0012	0.0196	CbGpPWpGaD
Lercanidipine—Nifedipine—CYP1A1—chronic obstructive pulmonary disease	0.00106	0.219	CrCbGaD
Lercanidipine—Nifedipine—CYP1A2—chronic obstructive pulmonary disease	0.00103	0.212	CrCbGaD
Lercanidipine—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000946	0.0154	CbGpPWpGaD
Lercanidipine—CYP3A5—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000916	0.0149	CbGpPWpGaD
Lercanidipine—CYP3A7—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000883	0.0144	CbGpPWpGaD
Lercanidipine—CYP3A5—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000879	0.0143	CbGpPWpGaD
Lercanidipine—CYP3A5—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000845	0.0138	CbGpPWpGaD
Lercanidipine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000747	0.0122	CbGpPWpGaD
Lercanidipine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000725	0.0118	CbGpPWpGaD
Lercanidipine—CYP3A5—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000639	0.0104	CbGpPWpGaD
Lercanidipine—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000625	0.0102	CbGpPWpGaD
Lercanidipine—CYP3A5—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000614	0.00999	CbGpPWpGaD
Lercanidipine—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000601	0.00978	CbGpPWpGaD
Lercanidipine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000592	0.00158	CcSEcCtD
Lercanidipine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000592	0.00158	CcSEcCtD
Lercanidipine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000592	0.00158	CcSEcCtD
Lercanidipine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000592	0.00158	CcSEcCtD
Lercanidipine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000592	0.00158	CcSEcCtD
Lercanidipine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00059	0.00158	CcSEcCtD
Lercanidipine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00059	0.00158	CcSEcCtD
Lercanidipine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00059	0.00158	CcSEcCtD
Lercanidipine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00059	0.00158	CcSEcCtD
Lercanidipine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00059	0.00158	CcSEcCtD
Lercanidipine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000589	0.00158	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000588	0.00157	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000588	0.00157	CcSEcCtD
Lercanidipine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000585	0.00157	CcSEcCtD
Lercanidipine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000585	0.00157	CcSEcCtD
Lercanidipine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00058	0.00155	CcSEcCtD
Lercanidipine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00058	0.00155	CcSEcCtD
Lercanidipine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00058	0.00155	CcSEcCtD
Lercanidipine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000579	0.00155	CcSEcCtD
Lercanidipine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000579	0.00155	CcSEcCtD
Lercanidipine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000578	0.00155	CcSEcCtD
Lercanidipine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000577	0.00154	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000576	0.00154	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000575	0.00154	CcSEcCtD
Lercanidipine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000573	0.00153	CcSEcCtD
Lercanidipine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000562	0.00915	CbGpPWpGaD
Lercanidipine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000559	0.0015	CcSEcCtD
Lercanidipine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000559	0.0015	CcSEcCtD
Lercanidipine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000559	0.0015	CcSEcCtD
Lercanidipine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000559	0.0015	CcSEcCtD
Lercanidipine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000557	0.00149	CcSEcCtD
Lercanidipine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000557	0.00149	CcSEcCtD
Lercanidipine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000557	0.00149	CcSEcCtD
Lercanidipine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000556	0.00149	CcSEcCtD
Lercanidipine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000554	0.00148	CcSEcCtD
Lercanidipine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000554	0.00148	CcSEcCtD
Lercanidipine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000552	0.00148	CcSEcCtD
Lercanidipine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000552	0.00148	CcSEcCtD
Lercanidipine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000551	0.00148	CcSEcCtD
Lercanidipine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000551	0.00148	CcSEcCtD
Lercanidipine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00055	0.00147	CcSEcCtD
Lercanidipine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000547	0.00146	CcSEcCtD
Lercanidipine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000545	0.00146	CcSEcCtD
Lercanidipine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000544	0.00146	CcSEcCtD
Lercanidipine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000543	0.00883	CbGpPWpGaD
Lercanidipine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00054	0.00145	CcSEcCtD
Lercanidipine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00053	0.00142	CcSEcCtD
Lercanidipine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00053	0.00142	CcSEcCtD
Lercanidipine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00053	0.00142	CcSEcCtD
Lercanidipine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000528	0.00141	CcSEcCtD
Lercanidipine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000527	0.00141	CcSEcCtD
Lercanidipine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000527	0.00141	CcSEcCtD
Lercanidipine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000526	0.00141	CcSEcCtD
Lercanidipine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000523	0.0014	CcSEcCtD
Lercanidipine—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000523	0.0014	CcSEcCtD
Lercanidipine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000521	0.00139	CcSEcCtD
Lercanidipine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000518	0.00139	CcSEcCtD
Lercanidipine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000518	0.00139	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000517	0.00138	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000517	0.00138	CcSEcCtD
Lercanidipine—CYP3A7—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000516	0.0084	CbGpPWpGaD
Lercanidipine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000513	0.00137	CcSEcCtD
Lercanidipine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000513	0.00137	CcSEcCtD
Lercanidipine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000511	0.00137	CcSEcCtD
Lercanidipine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00051	0.00137	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000507	0.00136	CcSEcCtD
Lercanidipine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000506	0.00135	CcSEcCtD
Lercanidipine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000506	0.00135	CcSEcCtD
Lercanidipine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000505	0.00822	CbGpPWpGaD
Lercanidipine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000505	0.00135	CcSEcCtD
Lercanidipine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000505	0.00135	CcSEcCtD
Lercanidipine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000503	0.00135	CcSEcCtD
Lercanidipine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000501	0.00134	CcSEcCtD
Lercanidipine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.0005	0.00134	CcSEcCtD
Lercanidipine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.0005	0.00134	CcSEcCtD
Lercanidipine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000499	0.00134	CcSEcCtD
Lercanidipine—CYP3A7—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000498	0.00811	CbGpPWpGaD
Lercanidipine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000498	0.00133	CcSEcCtD
Lercanidipine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000494	0.00132	CcSEcCtD
Lercanidipine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000493	0.00132	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00049	0.00131	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00049	0.00131	CcSEcCtD
Lercanidipine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000489	0.00131	CcSEcCtD
Lercanidipine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000489	0.00131	CcSEcCtD
Lercanidipine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000489	0.00131	CcSEcCtD
Lercanidipine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000488	0.00795	CbGpPWpGaD
Lercanidipine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000488	0.00131	CcSEcCtD
Lercanidipine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000485	0.0013	CcSEcCtD
Lercanidipine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000485	0.0013	CcSEcCtD
Lercanidipine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000485	0.0013	CcSEcCtD
Lercanidipine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000481	0.00129	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00048	0.00128	CcSEcCtD
Lercanidipine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000479	0.00128	CcSEcCtD
Lercanidipine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000478	0.00128	CcSEcCtD
Lercanidipine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000477	0.00128	CcSEcCtD
Lercanidipine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000475	0.00127	CcSEcCtD
Lercanidipine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000474	0.00127	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000473	0.00126	CcSEcCtD
Lercanidipine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000473	0.00126	CcSEcCtD
Lercanidipine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000472	0.00126	CcSEcCtD
Lercanidipine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00047	0.00126	CcSEcCtD
Lercanidipine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00047	0.00126	CcSEcCtD
Lercanidipine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000468	0.00125	CcSEcCtD
Lercanidipine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000468	0.00125	CcSEcCtD
Lercanidipine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000467	0.00125	CcSEcCtD
Lercanidipine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000466	0.00125	CcSEcCtD
Lercanidipine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000466	0.00125	CcSEcCtD
Lercanidipine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000465	0.00124	CcSEcCtD
Lercanidipine—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000464	0.00755	CbGpPWpGaD
Lercanidipine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000464	0.00124	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000464	0.00124	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000463	0.00124	CcSEcCtD
Lercanidipine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000462	0.00124	CcSEcCtD
Lercanidipine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000458	0.00123	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000455	0.00122	CcSEcCtD
Lercanidipine—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000454	0.00739	CbGpPWpGaD
Lercanidipine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000451	0.00121	CcSEcCtD
Lercanidipine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000451	0.00121	CcSEcCtD
Lercanidipine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000449	0.0012	CcSEcCtD
Lercanidipine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000449	0.0012	CcSEcCtD
Lercanidipine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000449	0.0012	CcSEcCtD
Lercanidipine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000449	0.0012	CcSEcCtD
Lercanidipine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000447	0.0012	CcSEcCtD
Lercanidipine—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000445	0.00723	CbGpPWpGaD
Lercanidipine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000444	0.00119	CcSEcCtD
Lercanidipine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000443	0.00119	CcSEcCtD
Lercanidipine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000443	0.00119	CcSEcCtD
Lercanidipine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000442	0.00118	CcSEcCtD
Lercanidipine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000442	0.00118	CcSEcCtD
Lercanidipine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000441	0.00118	CcSEcCtD
Lercanidipine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00044	0.00118	CcSEcCtD
Lercanidipine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00044	0.00118	CcSEcCtD
Lercanidipine—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000439	0.00117	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000438	0.00117	CcSEcCtD
Lercanidipine—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000437	0.00711	CbGpPWpGaD
Lercanidipine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000426	0.00114	CcSEcCtD
Lercanidipine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000426	0.00693	CbGpPWpGaD
Lercanidipine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000424	0.00113	CcSEcCtD
Lercanidipine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000424	0.00113	CcSEcCtD
Lercanidipine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000418	0.00112	CcSEcCtD
Lercanidipine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000418	0.00112	CcSEcCtD
Lercanidipine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000418	0.00112	CcSEcCtD
Lercanidipine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00041	0.0011	CcSEcCtD
Lercanidipine—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000409	0.00666	CbGpPWpGaD
Lercanidipine—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000409	0.00665	CbGpPWpGaD
Lercanidipine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000407	0.00109	CcSEcCtD
Lercanidipine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000407	0.00109	CcSEcCtD
Lercanidipine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000402	0.00107	CcSEcCtD
Lercanidipine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000402	0.00107	CcSEcCtD
Lercanidipine—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000401	0.00107	CcSEcCtD
Lercanidipine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000401	0.00107	CcSEcCtD
Lercanidipine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000399	0.00107	CcSEcCtD
Lercanidipine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.00106	CcSEcCtD
Lercanidipine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000393	0.00105	CcSEcCtD
Lercanidipine—CACNA1D—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.000393	0.0064	CbGpPWpGaD
Lercanidipine—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000393	0.00639	CbGpPWpGaD
Lercanidipine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000388	0.00104	CcSEcCtD
Lercanidipine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000388	0.00104	CcSEcCtD
Lercanidipine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000385	0.00103	CcSEcCtD
Lercanidipine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000385	0.00103	CcSEcCtD
Lercanidipine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000383	0.00102	CcSEcCtD
Lercanidipine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00038	0.00102	CcSEcCtD
Lercanidipine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000379	0.00101	CcSEcCtD
Lercanidipine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000377	0.00101	CcSEcCtD
Lercanidipine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000375	0.001	CcSEcCtD
Lercanidipine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000375	0.001	CcSEcCtD
Lercanidipine—CYP3A5—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000373	0.00607	CbGpPWpGaD
Lercanidipine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000368	0.000984	CcSEcCtD
Lercanidipine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000367	0.000983	CcSEcCtD
Lercanidipine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000367	0.00597	CbGpPWpGaD
Lercanidipine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000367	0.000982	CcSEcCtD
Lercanidipine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000365	0.00594	CbGpPWpGaD
Lercanidipine—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000362	0.00589	CbGpPWpGaD
Lercanidipine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000362	0.000968	CcSEcCtD
Lercanidipine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000361	0.000966	CcSEcCtD
Lercanidipine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000361	0.000966	CcSEcCtD
Lercanidipine—CYP3A5—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00036	0.00586	CbGpPWpGaD
Lercanidipine—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.00036	0.00586	CbGpPWpGaD
Lercanidipine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000358	0.000958	CcSEcCtD
Lercanidipine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000358	0.000958	CcSEcCtD
Lercanidipine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000358	0.000957	CcSEcCtD
Lercanidipine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000358	0.000957	CcSEcCtD
Lercanidipine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000356	0.000952	CcSEcCtD
Lercanidipine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000356	0.000952	CcSEcCtD
Lercanidipine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000355	0.00095	CcSEcCtD
Lercanidipine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000355	0.00577	CbGpPWpGaD
Lercanidipine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.000949	CcSEcCtD
Lercanidipine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000354	0.000946	CcSEcCtD
Lercanidipine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000351	0.000938	CcSEcCtD
Lercanidipine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00035	0.000937	CcSEcCtD
Lercanidipine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00035	0.000935	CcSEcCtD
Lercanidipine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000348	0.000932	CcSEcCtD
Lercanidipine—CACNA1C—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.000346	0.00562	CbGpPWpGaD
Lercanidipine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000345	0.000924	CcSEcCtD
Lercanidipine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000344	0.000921	CcSEcCtD
Lercanidipine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000343	0.000919	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000343	0.000919	CcSEcCtD
Lercanidipine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000341	0.000912	CcSEcCtD
Lercanidipine—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000341	0.00554	CbGpPWpGaD
Lercanidipine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00034	0.000909	CcSEcCtD
Lercanidipine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000338	0.000906	CcSEcCtD
Lercanidipine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.000904	CcSEcCtD
Lercanidipine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000338	0.000904	CcSEcCtD
Lercanidipine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.000904	CcSEcCtD
Lercanidipine—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000337	0.00549	CbGpPWpGaD
Lercanidipine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000337	0.000902	CcSEcCtD
Lercanidipine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000337	0.000902	CcSEcCtD
Lercanidipine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000336	0.000899	CcSEcCtD
Lercanidipine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000331	0.000886	CcSEcCtD
Lercanidipine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00033	0.000884	CcSEcCtD
Lercanidipine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000323	0.00526	CbGpPWpGaD
Lercanidipine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000318	0.000852	CcSEcCtD
Lercanidipine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000317	0.000848	CcSEcCtD
Lercanidipine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000309	0.000827	CcSEcCtD
Lercanidipine—CACNA1D—Alzheimers Disease—IL1B—chronic obstructive pulmonary disease	0.000303	0.00493	CbGpPWpGaD
Lercanidipine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000302	0.000809	CcSEcCtD
Lercanidipine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.0003	0.000803	CcSEcCtD
Lercanidipine—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000297	0.00484	CbGpPWpGaD
Lercanidipine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000297	0.000795	CcSEcCtD
Lercanidipine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000297	0.00483	CbGpPWpGaD
Lercanidipine—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000296	0.00481	CbGpPWpGaD
Lercanidipine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000294	0.000786	CcSEcCtD
Lercanidipine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000292	0.000781	CcSEcCtD
Lercanidipine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000286	0.00465	CbGpPWpGaD
Lercanidipine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000285	0.000764	CcSEcCtD
Lercanidipine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000284	0.00076	CcSEcCtD
Lercanidipine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000278	0.000744	CcSEcCtD
Lercanidipine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000278	0.000744	CcSEcCtD
Lercanidipine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000276	0.000739	CcSEcCtD
Lercanidipine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000276	0.000737	CcSEcCtD
Lercanidipine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000274	0.000733	CcSEcCtD
Lercanidipine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000274	0.000733	CcSEcCtD
Lercanidipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000267	0.00435	CbGpPWpGaD
Lercanidipine—CACNA1C—Alzheimers Disease—IL1B—chronic obstructive pulmonary disease	0.000266	0.00433	CbGpPWpGaD
Lercanidipine—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000265	0.00432	CbGpPWpGaD
Lercanidipine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000265	0.00431	CbGpPWpGaD
Lercanidipine—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000262	0.00426	CbGpPWpGaD
Lercanidipine—CYP3A7—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000262	0.00426	CbGpPWpGaD
Lercanidipine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00026	0.00422	CbGpPWpGaD
Lercanidipine—CYP3A7—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000259	0.00421	CbGpPWpGaD
Lercanidipine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000258	0.00069	CcSEcCtD
Lercanidipine—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000256	0.00417	CbGpPWpGaD
Lercanidipine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000254	0.00068	CcSEcCtD
Lercanidipine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000253	0.000678	CcSEcCtD
Lercanidipine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000253	0.000677	CcSEcCtD
Lercanidipine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.00025	0.000669	CcSEcCtD
Lercanidipine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000247	0.000661	CcSEcCtD
Lercanidipine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000246	0.000658	CcSEcCtD
Lercanidipine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000245	0.000657	CcSEcCtD
Lercanidipine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000244	0.000654	CcSEcCtD
Lercanidipine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000241	0.000644	CcSEcCtD
Lercanidipine—CACNA1D—Metabolism—APIP—chronic obstructive pulmonary disease	0.000236	0.00384	CbGpPWpGaD
Lercanidipine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000233	0.000624	CcSEcCtD
Lercanidipine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000233	0.000624	CcSEcCtD
Lercanidipine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000232	0.000622	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000231	0.000619	CcSEcCtD
Lercanidipine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00023	0.000616	CcSEcCtD
Lercanidipine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000227	0.000606	CcSEcCtD
Lercanidipine—Shock—Prednisone—chronic obstructive pulmonary disease	0.00022	0.000588	CcSEcCtD
Lercanidipine—CACNA1D—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.00022	0.00357	CbGpPWpGaD
Lercanidipine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000586	CcSEcCtD
Lercanidipine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000218	0.000584	CcSEcCtD
Lercanidipine—CYP3A7—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000217	0.00354	CbGpPWpGaD
Lercanidipine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000217	0.000581	CcSEcCtD
Lercanidipine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000216	0.000578	CcSEcCtD
Lercanidipine—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000215	0.0035	CbGpPWpGaD
Lercanidipine—CYP3A7—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000214	0.00349	CbGpPWpGaD
Lercanidipine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000213	0.00057	CcSEcCtD
Lercanidipine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00021	0.00342	CbGpPWpGaD
Lercanidipine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00021	0.00341	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—APIP—chronic obstructive pulmonary disease	0.000208	0.00338	CbGpPWpGaD
Lercanidipine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000204	0.000545	CcSEcCtD
Lercanidipine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000203	0.000544	CcSEcCtD
Lercanidipine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000202	0.000541	CcSEcCtD
Lercanidipine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000201	0.000537	CcSEcCtD
Lercanidipine—CACNA1D—NCAM signaling for neurite out-growth—IL6—chronic obstructive pulmonary disease	0.0002	0.00325	CbGpPWpGaD
Lercanidipine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000526	CcSEcCtD
Lercanidipine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000194	0.00052	CcSEcCtD
Lercanidipine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.000519	CcSEcCtD
Lercanidipine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.000518	CcSEcCtD
Lercanidipine—CACNA1D—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.000194	0.00315	CbGpPWpGaD
Lercanidipine—CACNA1C—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.000193	0.00314	CbGpPWpGaD
Lercanidipine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000193	0.000515	CcSEcCtD
Lercanidipine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000193	0.000515	CcSEcCtD
Lercanidipine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000191	0.000511	CcSEcCtD
Lercanidipine—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000189	0.00308	CbGpPWpGaD
Lercanidipine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000189	0.00307	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000187	0.00304	CbGpPWpGaD
Lercanidipine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000186	0.00303	CbGpPWpGaD
Lercanidipine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000184	0.000493	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000489	CcSEcCtD
Lercanidipine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000183	0.000489	CcSEcCtD
Lercanidipine—CYP3A7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000181	0.00295	CbGpPWpGaD
Lercanidipine—CYP3A7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000179	0.00291	CbGpPWpGaD
Lercanidipine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000475	CcSEcCtD
Lercanidipine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000473	CcSEcCtD
Lercanidipine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000473	CcSEcCtD
Lercanidipine—CACNA1D—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000176	0.00287	CbGpPWpGaD
Lercanidipine—CACNA1C—NCAM signaling for neurite out-growth—IL6—chronic obstructive pulmonary disease	0.000176	0.00286	CbGpPWpGaD
Lercanidipine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000174	0.00282	CbGpPWpGaD
Lercanidipine—CACNA1C—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.00017	0.00277	CbGpPWpGaD
Lercanidipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00017	0.00276	CbGpPWpGaD
Lercanidipine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000167	0.00272	CbGpPWpGaD
Lercanidipine—CYP3A7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000167	0.00271	CbGpPWpGaD
Lercanidipine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00044	CcSEcCtD
Lercanidipine—CYP3A7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000164	0.00267	CbGpPWpGaD
Lercanidipine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000429	CcSEcCtD
Lercanidipine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000423	CcSEcCtD
Lercanidipine—CYP3A7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000158	0.00257	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000157	0.00256	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000156	0.00255	CbGpPWpGaD
Lercanidipine—CYP3A7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000156	0.00254	CbGpPWpGaD
Lercanidipine—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000155	0.00252	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000155	0.00252	CbGpPWpGaD
Lercanidipine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000409	CcSEcCtD
Lercanidipine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000153	0.00249	CbGpPWpGaD
Lercanidipine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000152	0.00248	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GC—chronic obstructive pulmonary disease	0.000152	0.00248	CbGpPWpGaD
Lercanidipine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000395	CcSEcCtD
Lercanidipine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00038	CcSEcCtD
Lercanidipine—CACNA1D—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000141	0.0023	CbGpPWpGaD
Lercanidipine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000377	CcSEcCtD
Lercanidipine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000377	CcSEcCtD
Lercanidipine—Headache—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000375	CcSEcCtD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000138	0.00224	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000137	0.00224	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000134	0.00219	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GC—chronic obstructive pulmonary disease	0.000134	0.00218	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000133	0.00216	CbGpPWpGaD
Lercanidipine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000355	CcSEcCtD
Lercanidipine—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000131	0.00213	CbGpPWpGaD
Lercanidipine—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000129	0.0021	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000127	0.00207	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000124	0.00202	CbGpPWpGaD
Lercanidipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000123	0.00201	CbGpPWpGaD
Lercanidipine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000122	0.00198	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.00012	0.00196	CbGpPWpGaD
Lercanidipine—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000119	0.00193	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000114	0.00186	CbGpPWpGaD
Lercanidipine—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000113	0.00183	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000112	0.00182	CbGpPWpGaD
Lercanidipine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.00179	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.00011	0.00178	CbGpPWpGaD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.99e-05	0.00163	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—LEP—chronic obstructive pulmonary disease	9.63e-05	0.00157	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.32e-05	0.00152	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—MMP9—chronic obstructive pulmonary disease	9.23e-05	0.0015	CbGpPWpGaD
Lercanidipine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.19e-05	0.0015	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	9.19e-05	0.00149	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.79e-05	0.00143	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.69e-05	0.00141	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.57e-05	0.00139	CbGpPWpGaD
Lercanidipine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.45e-05	0.00137	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.42e-05	0.00137	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.31e-05	0.00135	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—VEGFA—chronic obstructive pulmonary disease	8.29e-05	0.00135	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GCLC—chronic obstructive pulmonary disease	8.22e-05	0.00134	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	8.19e-05	0.00133	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.12e-05	0.00132	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—MMP9—chronic obstructive pulmonary disease	8.11e-05	0.00132	CbGpPWpGaD
Lercanidipine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.01e-05	0.0013	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.61e-05	0.00124	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CTGF—chronic obstructive pulmonary disease	7.5e-05	0.00122	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—EGFR—chronic obstructive pulmonary disease	7.46e-05	0.00121	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.31e-05	0.00119	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.31e-05	0.00119	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—VEGFA—chronic obstructive pulmonary disease	7.28e-05	0.00118	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GCLC—chronic obstructive pulmonary disease	7.22e-05	0.00118	CbGpPWpGaD
Lercanidipine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.21e-05	0.00117	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.91e-05	0.00112	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CTGF—chronic obstructive pulmonary disease	6.59e-05	0.00107	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—MMP9—chronic obstructive pulmonary disease	6.59e-05	0.00107	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—EGFR—chronic obstructive pulmonary disease	6.55e-05	0.00107	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	6.53e-05	0.00106	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.09e-05	0.000992	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.09e-05	0.00099	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.07e-05	0.000988	CbGpPWpGaD
Lercanidipine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.01e-05	0.000978	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	5.92e-05	0.000963	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	5.91e-05	0.000962	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—MMP9—chronic obstructive pulmonary disease	5.79e-05	0.000942	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.76e-05	0.000938	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—IL6—chronic obstructive pulmonary disease	5.73e-05	0.000933	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.68e-05	0.000925	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.6e-05	0.000911	CbGpPWpGaD
Lercanidipine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.52e-05	0.000899	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.5e-05	0.000895	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	5.43e-05	0.000883	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—EGFR—chronic obstructive pulmonary disease	5.32e-05	0.000866	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.31e-05	0.000864	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.3e-05	0.000862	CbGpPWpGaD
Lercanidipine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.24e-05	0.000852	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	5.2e-05	0.000845	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—TNF—chronic obstructive pulmonary disease	5.07e-05	0.000825	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.06e-05	0.000824	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—IL6—chronic obstructive pulmonary disease	5.04e-05	0.000819	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.02e-05	0.000817	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.99e-05	0.000813	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	4.77e-05	0.000776	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—EGFR—chronic obstructive pulmonary disease	4.68e-05	0.000761	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.65e-05	0.000757	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.47e-05	0.000728	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—TNF—chronic obstructive pulmonary disease	4.45e-05	0.000725	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	4.42e-05	0.00072	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.41e-05	0.000718	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.33e-05	0.000704	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.27e-05	0.000695	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	4.21e-05	0.000685	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—IL6—chronic obstructive pulmonary disease	4.09e-05	0.000665	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	4.04e-05	0.000657	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.91e-05	0.000637	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.72e-05	0.000605	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—IL6—chronic obstructive pulmonary disease	3.59e-05	0.000585	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ALB—chronic obstructive pulmonary disease	3.41e-05	0.000555	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—NOS3—chronic obstructive pulmonary disease	3.26e-05	0.000531	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.23e-05	0.000526	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	3.2e-05	0.00052	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.1e-05	0.000505	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.06e-05	0.000498	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ALB—chronic obstructive pulmonary disease	3e-05	0.000488	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	2.92e-05	0.000475	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—NOS3—chronic obstructive pulmonary disease	2.87e-05	0.000467	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.85e-05	0.000464	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.83e-05	0.00046	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.75e-05	0.000448	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.7e-05	0.00044	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.69e-05	0.000437	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.56e-05	0.000416	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.3e-05	0.000374	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.27e-05	0.00037	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.24e-05	0.000365	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.21e-05	0.00036	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.07e-05	0.000338	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.06e-05	0.000335	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.95e-05	0.000318	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.91e-05	0.000311	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	1.84e-05	0.000299	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.76e-05	0.000286	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.59e-05	0.000259	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.57e-05	0.000256	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.5e-05	0.000245	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.49e-05	0.000242	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.46e-05	0.000238	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.39e-05	0.000226	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.36e-05	0.000221	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	1.33e-05	0.000216	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.27e-05	0.000207	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.25e-05	0.000203	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.04e-05	0.00017	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.03e-05	0.000167	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.58e-06	0.000156	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	9.44e-06	0.000154	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.08e-06	0.000148	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	9.03e-06	0.000147	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	6.17e-06	0.0001	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.9e-06	9.61e-05	CbGpPWpGaD
